HIGHLIGHTS
- who: . and collaborators from the Wayne State University, United States have published the research work: Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells mitochondrial, in the Journal: (JOURNAL)
- what: The authors investigated the antitumor effects of ivermectin in pancreatic cancer.
- how: The results showed that the combination treatment further reduced the expression levels of CDK4 and CDK6 compared to gemcitabine treatment alone .
SUMMARY
The 5-year survival rate is less than 10% (Jia et_al, 2019; Hyatt and Powers, 2021; Lee et_al, 2021) owing to late diagnosis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.